Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Parkinsonism Relat Disord. 2016 Jun 16;30:40–45. doi: 10.1016/j.parkreldis.2016.06.010

Table 1.

Subjects characteristics

Variable Pathologically confirmed
MSA patients (N=127)		 Clinically diagnosed
MSA patients (N=86)		 Controls (N=1312)
Age (years)1 67 (47, 91) 67 (45, 88) 69 (45, 92)
Gender
   Male 75 (59.1%) 49 (57.0%) 611 (46.6%)
   Female 42 (40.9%) 37 (43.0%) 701 (53.4%)
MSA subtype
   MSA-P 51 (40.2%) 52 (60.5%) N/A
   MSA-C 20 (15.7%) 24 (27.9%) N/A
   MSA-mixed 56 (44.1%) 10 (11.6%) N/A

The sample median (range) is given for age.

1

Age at death is given for pathologically confirmed MSA patients and age at blood collection is given for controls and clinically diagnosed MSA patients. MSA=multiple system atrophy.